SAN DIEGO, March 19, 2018 -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain purchasers of NYSE: BW shares against Babcock & Wilcox Enterprises Inc.
Investors, who purchased shares of Babcock & Wilcox Enterprises Inc (NYSE:BW) in 2015 or earlier and continue to hold any of those NYSE: BW shares, have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
On March 3, 2017, 2015, a lawsuit was filed against Babcock & Wilcox Enterprises Inc over alleged securities laws violations. The plaintiff alleged that the Company was experiencing significant, undisclosed problems in its Renewable segment. The plaintiff claimed that although defendants disclosed issues with a single project in the Renewable business on June 28, 2016, they failed to disclose that similar problems were significantly and negatively impacting other projects in the Company's Renewable segment, instead assuring investors during a business update call that the problems were "a single project issue."
On September 28, 2017, an amended complaint was filed and on November 13, 2017, the defendants filed their motion to dismiss the case. On February 8, 2018, the judge denied the defendants’ motion to dismiss the lawsuit.
Those who purchased Babcock & Wilcox Enterprises Inc (NYSE:BW) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
[email protected]
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108


Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Washington Post Publisher Will Lewis Steps Down After Layoffs
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



